Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Condition:   Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection) Intervention:   Other: convalescent plasma application to SARS-CoV-2 infected patients Sponsor:   University Hospital, Basel, Switzerland Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials